New pill targets rare Cancer's genetic driver
NCT ID NCT06118086
Summary
This early-stage study is testing a new oral medication called REM-422 for people with advanced adenoid cystic carcinoma (ACC), a rare cancer. The main goals are to find a safe and effective dose and to see if the drug can shrink or control tumors. The study will enroll about 100 adults whose cancer has returned, spread, or cannot be removed by surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOID CYSTIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Antoine Lacassagne
NOT_YET_RECRUITINGNice, 06189, France
Contact
-
Dana Farber Cancer Research Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
-
Institut de Cancerologie Gustave-Roussy
NOT_YET_RECRUITINGVillejuif, 94805, France
Contact
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
Contact
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
Contact
-
University of California San Francisco Helen Diller Comprehensive Cancer Center
RECRUITINGSan Francisco, California, 94143, United States
Contact
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Conditions
Explore the condition pages connected to this study.